Bristol Myers Squibb Cash Flow from Financial Activities 2010-2025 | BMY
Bristol Myers Squibb cash flow from financial activities for the twelve months ending March 31, 2025 was $21.524B, a 307.4% decline year-over-year.
- Bristol Myers Squibb annual cash flow from financial activities for 2024 was $5.127B, a 154.45% decline from 2023.
- Bristol Myers Squibb annual cash flow from financial activities for 2023 was $-9.416B, a 44.49% decline from 2022.
- Bristol Myers Squibb annual cash flow from financial activities for 2022 was $-16.962B, a 4.55% increase from 2021.